|
|
Volumn 40, Issue 3, 1995, Pages 277-280
|
|
Single dose pharmacokinetics, safety and tolerability of MK‐0476, a new leukotriene D4‐receptor antagonist, in healthy volunteers.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
LEUKOTRIENE D4;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
MONTELUKAST;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DOUBLE BLIND PROCEDURE;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG DOSAGE FORM;
DRUG SAFETY;
FLUSHING;
HEADACHE;
HUMAN;
HUMAN EXPERIMENT;
MALE;
NORMAL HUMAN;
ORAL DRUG ADMINISTRATION;
PHARMACOKINETICS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
VOLUNTEER;
ACETATES;
ADMINISTRATION, ORAL;
ADULT;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG TOLERANCE;
HUMANS;
MALE;
QUINOLINES;
RECEPTORS, DOPAMINE;
SAFETY;
TIME FACTORS;
|
|
EID: 0029118653
PISSN: 03065251
EISSN: 13652125
Source Type: Journal
DOI: 10.1111/j.1365-2125.1995.tb05785.x Document Type: Article |
|
Times cited : (71)
|
|
References (9)
|
